Chapter 74: PEARS for Uterine Leiomyomata: Myomectomy
RRM Methods > NaProTECHNOLOGY > Clinical OutcomesRRM Methods > NaProTECHNOLOGY > ProtocolInfertility > Female Factor > Unexplained
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial
International Journal of Food Sciences and Nutrition, 72(5), 670-679
Abstract
This study aims to evaluate the effects of myo-inositol supplementation on gestational diabetes mellitus (GDM) rates and body water distribution in overweight non-obese women. 223 overweight non-obese women pregnant were randomly assigned to the treatment group (2 g of myo-inositol plus 200 µg of folic acid) or to the placebo one (200 µg of folic acid). The treatment lasted until three weeks after delivery. A tetrapolar impedance analyser was used to study body composition. The incidence of GDM was significantly reduced in the myo-inositol group compared with the placebo group. There was a significant increase in TBW, ECW and ICW values in the placebo group compared to the myo-inositol group. We have recorded a significant reduction in the overall incidence of pregnancy-induced hypertension in the myo-inositol group compared with the placebo group. Our results demonstrate the effectiveness of myo-inositol supplementation in preventing GDM in overweight non-obese pregnant women.
Topics
Cite this article
Vitale, S. G., Corrado, F., Caruso, S., Giunta, L., Cianci, A., D'Anna, R., & Di Benedetto, A. (2020). Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial. *International journal of food sciences and nutrition*, *72*(5), 670-679. https://doi.org/10.1080/09637486.2020.1852191
Vitale SG, Corrado F, Caruso S, Giunta L, Cianci A, D'Anna R, et al. Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial. Int J Food Sci Nutr. 2020;72(5):670-679. doi:10.1080/09637486.2020.1852191
Vitale, S. G., et al. "Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial." *International journal of food sciences and nutrition*, vol. 72, no. 5, 2020, pp. 670-679.
Keywords
Inositol, Folic Acid,